Chemoinformaics analysis of N-[4-(ACRIDIN-9-YLAMINO)-3-METHOXYPHENYL]METHANESULFONAMIDE
| Molecular Weight | 393.468 | nRot | 5 |
| Heavy Atom Molecular Weight | 374.316 | nRig | 25 |
| Exact Molecular Weight | 393.115 | nRing | 4 |
| Solubility: LogS | -4.423 | nHRing | 1 |
| Solubility: LogP | 3.402 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 3 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 3 | No. of Arom Atom | 20 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 22 |
| nHA | 5 | APOL | 56.3451 |
| nHD | 2 | BPOL | 29.7329 |
| QED | 0.515 |
| Synth | 2.469 |
| Natural Product Likeliness | -0.859 |
| NR-PPAR-gamma | 0.102 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.618 |
| Pgp-sub | 0.993 |
| HIA | 0.008 |
| CACO-2 | -5.743 |
| MDCK | 0.00000872 |
| BBB | 0.033 |
| PPB | 0.972984 |
| VDSS | 0.568 |
| FU | 0.00882139 |
| CYP1A2-inh | 0.992 |
| CYP1A2-sub | 0.923 |
| CYP2c19-inh | 0.952 |
| CYP2c19-sub | 0.164 |
| CYP2c9-inh | 0.907 |
| CYP2c9-sub | 0.921 |
| CYP2d6-inh | 0.937 |
| CYP2d6-sub | 0.867 |
| CYP3a4-inh | 0.903 |
| CYP3a4-sub | 0.919 |
| CL | 2.138 |
| T12 | 0.274 |
| hERG | 0.668 |
| Ames | 0.94 |
| ROA | 0.765 |
| SkinSen | 0.753 |
| Carcinogencity | 0.541 |
| EI | 0.08 |
| Respiratory | 0.97 |
| NR-Aromatase | 0.014 |
| Antiviral | Yes |
| Prediction | 0.858864 |